Get bit by a rattlesnake, ouch. Go to the hospital, get bill, OUCH!
- Thread starter Ace_on_the_Turn
- Start Date
Edit: Nevermind, their heads fell off this morning...
I've got a Timber Rattler and two Copperheads, let me know where to send them.
Last edited:
You're the one that just made the direct comparison. I guess the term "variable" is totally lost on you?
Hate to break it to you, but the stuff from trouser snakes isn't venom.
Anyone who wants to compare rebuilding (or even troubleshooting) a transmission to healthcare is more than free to go to their ASE Certified mechanic next time they get sick, if you ask me. Simple solution.
More details about the medical bill posted in the OP. Also, don't take selfies with rattlesnakes.
http://www.washingtonpost.com/blogs...s-everything-wrong-with-american-health-care/
"There's currently only one commercially-available antivenin for treating venomous snakebites in the U.S. -- CroFab, manufactured by U.K.-based BTG plc. And with a stable market of 7,000 to 8,000 snakebite victims per year and no competitors, business is pretty good. BTG's latest annual report shows CroFab sales topped out at close to $63 million British pounds, or $98 million dollars last fiscal year. The antivenin costs hospitals roughly $2,300 per vial, according to Bloomberg, with a typical dose requiring four to six vials. In some cases multiple doses are needed, according to CroFab's promotional website.
BTG has fought aggressively to keep competitors off the market. A competing product, Anavip, just received FDA approval this year and likely won't be on the market until late 2018. This lack of competition is one reason why snakebite treatments rack up such huge hospital bills -- $55,000. $89,000. $143,000. In May of this year, a snakebit Missouri man died after refusing to seek medical care, saying he couldn't afford the bill."
http://www.washingtonpost.com/blogs...s-everything-wrong-with-american-health-care/
"There's currently only one commercially-available antivenin for treating venomous snakebites in the U.S. -- CroFab, manufactured by U.K.-based BTG plc. And with a stable market of 7,000 to 8,000 snakebite victims per year and no competitors, business is pretty good. BTG's latest annual report shows CroFab sales topped out at close to $63 million British pounds, or $98 million dollars last fiscal year. The antivenin costs hospitals roughly $2,300 per vial, according to Bloomberg, with a typical dose requiring four to six vials. In some cases multiple doses are needed, according to CroFab's promotional website.
BTG has fought aggressively to keep competitors off the market. A competing product, Anavip, just received FDA approval this year and likely won't be on the market until late 2018. This lack of competition is one reason why snakebite treatments rack up such huge hospital bills -- $55,000. $89,000. $143,000. In May of this year, a snakebit Missouri man died after refusing to seek medical care, saying he couldn't afford the bill."
Last edited by a moderator:
Like I asked previously... what's an acceptable gross margin in your opinion?
Similar threads
